Financial Performance Overview (Combined Proforma)

Aster DM Quality Care Limited reported unaudited financial results for Q1 FY27 (quarter ended June 30, 2026) on a combined proforma basis following the merger with Quality Care India Limited.

Key Financial Metrics:

  • Revenue: ₹2,597 Cr, representing 20% YoY growth
  • Operating EBITDA: ₹576 Cr, representing 30% YoY growth
  • Operating EBITDA Margin: 22.2%, increased by 170 bps YoY
  • ROCE: 22.9%, increased by 246 bps YoY
  • Excluding Kasargod: Operating EBITDA grew 31% YoY with margin of 22.4% (190 bps expansion)
  • Kasargod Hospital achieved monthly EBITDA break-even within 9 months of operations

Segment Performance Breakdown

Aster DM Healthcare Performance (Q1 FY27):

  • Revenue: ₹1,311 Cr, 22% YoY growth
  • Operating EBITDA (ex-Kasaragod): ₹279 Cr, 30% YoY growth
  • Operating EBITDA Margins (ex-Kasaragod): 21.7% vs 20.0% in Q1 FY26
  • Normalised PAT (ex-Kasaragod): ₹131 Cr, 46% YoY growth
  • ARPP IP: ₹1,30,352, 10% YoY increase
  • Total patient volume: 16% YoY growth
  • Matured hospitals revenue growth: 19% YoY
  • Emerging hospitals revenue growth: 95% YoY

Quality Care Performance (Q1 FY27):

  • Revenue: ₹1,287 Cr, 19% YoY growth
  • Operating EBITDA: ₹299 Cr, 32% YoY growth
  • Operating EBITDA Margins: 23.2% vs 21.1% in Q1 FY26
  • ARPP IP: ₹1,44,064, 9% YoY increase
  • Total patient volume: 10% YoY growth
  • Matured hospital revenue growth: 18% YoY
  • Emerging units revenue growth: 47% YoY

Operational Highlights

  • Total patients served: 2 million in OP and IP in Q1 FY27, 13% more than previous year
  • Combined network: 39 hospitals across 28 cities with over 10,890 beds
  • Merger effective date: July 1, 2026
  • Brands integrated: Aster DM Healthcare, CARE Hospitals, Evercare, and KIMSHEALTH

Management Commentary

Dr. Azad Moopen, Executive Chairman:

Commented on the merger as a "defining milestone" creating one of India's leading integrated healthcare platforms. The merged entity aims to expand to more than 15,000 beds in coming years. Focus on combining medical talent with advanced technology, AI, robotics, research, and innovation to redefine healthcare delivery.

Mr. Varun Khanna, Managing Director & Group CEO:

Emphasized commitment to patient care, enabling doctors through technology, and best-in-class clinical outcomes. Focus for coming quarters is on disciplined execution, enhancing patient care, unlocking platform potential, and driving long-term value through operational excellence.

Disclaimer Note

The document contains forward-looking statements subject to risks and uncertainties. Quality Care numbers are indicative and subject to statutory audit adjustments. Proforma numbers for merger entity are subject to finalization and audit of merged accounts. Other factors that could cause actual results to differ include harmonization of accounting policies and practices.